Bye bye, bifocals? New eye drops can fix farsightedness
Posted:
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of once-daily drops that ease near-object blurriness for up to 10 hours.
Capital planning in healthcare is not merely an administrative obligation—it is a strategic discipline that shapes clinical capabilities, operational resilience and financial health.
Recognising and addressing common planning mistakes is essential to sustaining high-quality, efficient care in an increasingly complex…
The Gates Foundation said it is committing to invest $2.5 billion over the next five years to accelerate research and development in neglected areas of women’s health.
Lack of investment often slows the research necessary for biotechnology companies to develop new medicines,…
Attendees
Sponsors and Exhibitors
Contact us